Know How Bempedoic Acid Stacks Up to Other Non-Statins
You’ll hear buzz about bempedoic acid (Nilemdo), a new oral non-statin cholesterol med.
Bempedoic acid is the first “ATP citrate lyase inhibitor.” It blocks an earlier step in cholesterol synthesis in the liver compared to statins...and avoids the muscle activation that leads to myalgias.
Bempedoic acid lowers LDL another 20% or so when added to a max tolerated statin. It doesn’t have much impact on triglycerides or HDL.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive